90 related articles for article (PubMed ID: 22916267)
1. Cell-free circulating plasma hTERT mRNA is a useful marker for prostate cancer diagnosis and is associated with poor prognosis tumor characteristics.
March-Villalba JA; Martínez-Jabaloyas JM; Herrero MJ; Santamaria J; Aliño SF; Dasí F
PLoS One; 2012; 7(8):e43470. PubMed ID: 22916267
[TBL] [Abstract][Full Text] [Related]
2. Development of a multigenomic liquid biopsy (PROSTest) for prostate cancer in whole blood.
Modlin IM; Kidd M; Drozdov IA; Boegemann M; Bodei L; Kunikowska J; Malczewska A; Bernemann C; Koduru SV; Rahbar K
Prostate; 2024 Jun; 84(9):850-865. PubMed ID: 38571290
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3: a possible complementary marker to the PSA blood test.
Balan V; Wang Y; Nangia-Makker P; Kho D; Bajaj M; Smith D; Heilbrun L; Raz A; Heath E
Oncotarget; 2013 Apr; 4(4):542-9. PubMed ID: 23625538
[TBL] [Abstract][Full Text] [Related]
4. Novel molecular panel for evaluating systemic inflammation and survival in therapy naïve glioma patients.
Gandhi P; Shrivastava R; Garg N; Sorte SK
World J Clin Oncol; 2021 Oct; 12(10):947-959. PubMed ID: 34733616
[TBL] [Abstract][Full Text] [Related]
5. Is serum-derived exosomal hTERT transcript a marker of oncogenic activity in primary brain tumors? An exploratory study.
Uziel O; Kanner AA; Beery E; Lev S; Lahav M; Horn-Fichman S; Nof SH; Laviv Y; Katz SY; Amiel A; Shkara RA; Siddeeq M; Levi-Barda A; Raanani P; Sela Y; Cohen Z; Siegal T
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38155481
[TBL] [Abstract][Full Text] [Related]
6. A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history.
Kobayashi T
Cancer Med; 2018 Mar; 7(3):549-556. PubMed ID: 29464878
[TBL] [Abstract][Full Text] [Related]
7. Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer.
Smith SF; Brewer DS; Hurst R; Cooper CS
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730670
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment.
Chaddha M; Rai H; Gupta R; Thakral D
Front Genet; 2023; 14():1138625. PubMed ID: 37091783
[TBL] [Abstract][Full Text] [Related]
9. Telomere Length Changes in Cancer: Insights on Carcinogenesis and Potential for Non-Invasive Diagnostic Strategies.
Holesova Z; Krasnicanova L; Saade R; Pös O; Budis J; Gazdarica J; Repiska V; Szemes T
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980987
[TBL] [Abstract][Full Text] [Related]
10. Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome.
Laish I; Levi Z; Mahajna H; Albshesh A; Horesh N; Katz E; Feldman D; Shinar N; Picard O; Yavzori M; Fudim E; Raanani P; Berger T; Goldvaser H; Beery E; Uziel O
Front Oncol; 2022; 12():962473. PubMed ID: 36203446
[TBL] [Abstract][Full Text] [Related]
11. Integrative Analyses of Circulating mRNA and lncRNA Expression Profile in Plasma of Lung Cancer Patients.
Li H; Li M; Guo H; Lin G; Huang Q; Qiu M
Front Oncol; 2022; 12():843054. PubMed ID: 35433477
[TBL] [Abstract][Full Text] [Related]
12. Identification of Combinations of Plasma lncRNAs and mRNAs as Potential Biomarkers for Precursor Lesions and Early Gastric Cancer.
Chen L; Ge C; Feng X; Fu H; Wang S; Zhu J; Linghu E; Zheng X
J Oncol; 2022; 2022():1458320. PubMed ID: 35186077
[TBL] [Abstract][Full Text] [Related]
13. Biological Predictors of
Cangemi M; Zanussi S; Rampazzo E; Bidoli E; Giunco S; Tedeschi R; Pratesi C; Martorelli D; Casarotto M; Martellotta F; Schioppa O; Serraino D; Steffan A; De Rossi A; Dolcetti R; Vaccher E
Front Oncol; 2021; 11():772348. PubMed ID: 34746013
[TBL] [Abstract][Full Text] [Related]
14. Emerging Role of Extracellular Vesicles in Prostate Cancer.
Ludwig M; Rajvansh R; Drake JM
Endocrinology; 2021 Sep; 162(9):. PubMed ID: 34232289
[TBL] [Abstract][Full Text] [Related]
15. Label-free
DeLuna F; Ding X; Sagredo I; Bustamante G; Sun LZ; Ye JY
Proc SPIE Int Soc Opt Eng; 2018; 10504():. PubMed ID: 32528210
[TBL] [Abstract][Full Text] [Related]
16. Cellular Refractive Index Comparison of Various Prostate Cancer and Noncancerous Cell Lines via Photonic-Crystal Biosensor.
DeLuna F; Cadena M; Wang B; Sun LZ; Ye JY
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10881():. PubMed ID: 32313355
[TBL] [Abstract][Full Text] [Related]
17. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis.
Lapitz A; Arbelaiz A; O'Rourke CJ; Lavin JL; Casta A; Ibarra C; Jimeno JP; Santos-Laso A; Izquierdo-Sanchez L; Krawczyk M; Perugorria MJ; Jimenez-Aguero R; Sanchez-Campos A; Riaño I; Gónzalez E; Lammert F; Marzioni M; Macias RIR; Marin JJG; Karlsen TH; Bujanda L; Falcón-Pérez JM; Andersen JB; Aransay AM; Rodrigues PM; Banales JM
Cells; 2020 Mar; 9(3):. PubMed ID: 32183400
[No Abstract] [Full Text] [Related]
18. Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment.
Ganesh MS; Narayanan GS; Kumar R
Rep Pract Oncol Radiother; 2020; 25(1):28-34. PubMed ID: 31866769
[TBL] [Abstract][Full Text] [Related]
19. The Prospect and Challenges to the Flow of Liquid Biopsy in Africa.
Temilola DO; Wium M; Coulidiati TH; Adeola HA; Carbone GM; Catapano CV; Zerbini LF
Cells; 2019 Aug; 8(8):. PubMed ID: 31404988
[TBL] [Abstract][Full Text] [Related]
20. Utility of Circulating Cell-Free RNA Analysis for the Characterization of Global Transcriptome Profiles of Multiple Myeloma Patients.
Chen M; Mithraprabhu S; Ramachandran M; Choi K; Khong T; Spencer A
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31242667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
